Infliximab therapy reduces hospitalizations in ulcerative colitis patients

被引：0
|
作者：
Sandborn, WJ
Lichtenstein, GR
Colombel, JF
Yan, S
Sands, BE
Eisenberg, D
Olson, A
Rutgeerts, PJ
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Hosp Univ Penn, Philadelphia, PA 19104 USA
[3] CHU Lille, Hosp Claude Huriez, F-59037 Lille, France
[4] Centocor Inc, Outcomes Res, Malvern, PA 19355 USA
[5] Centocor Inc, Clin Res & Dev, Malvern, PA 19355 USA
[6] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[7] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
847
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [41] Pericarditis during infliximab therapy in paediatric ulcerative colitis
    Dipasquale, V.
    Gramaglia, S. M. C.
    Catena, M. A.
    Romano, C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (01) : 107 - 109
  • [42] Infliximab as rescue therapy for patients with severe ulcerative colitis: A single centre study
    Manuela, Fortuna
    Renzo, Montanari
    Andrea, Geccherle
    Alberto, Sartori
    Giacomo, Ruffo
    Maria, Chiaramonte
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 796 - 796
  • [43] Effectiveness of infliximab as remission-induction therapy in patients with active ulcerative colitis
    Yokoyama, K.
    Kawagishi, K.
    Ooka, S.
    Mukae, M.
    Sada, M.
    Kobayashi, K.
    Koizumi, W.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S277 - S277
  • [44] Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
    Mirza, Muhammad
    Mirza, Maira
    Murugesan, Vagishwari
    Olano, Arrel
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2018, 2018
  • [45] Biological therapy with infliximab in ulcerative colitis: Personal experience
    Bizzarri, Barbara
    Fornaroli, Fabiola
    de Angelis, Nicola
    Maffini, Valentina
    Vincenzi, Francesca
    de' Angelis, Gian Luigi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S460 - S460
  • [46] Pulmonary toxicity associated with infliximab therapy for ulcerative colitis
    Heraganahally, S. S.
    Au, V.
    Kondru, S.
    Edwards, S.
    Bowden, J. J.
    Sajkov, D.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (09) : 629 - 630
  • [47] EFFICACY OF INFLIXIMAB THERAPY IN ACUTE AND SUBACUTE ULCERATIVE COLITIS
    Harrison, E.
    Slater, J.
    Wood, L.
    Cooper, S. C.
    de Silva, S.
    GUT, 2012, 61 : A177 - A178
  • [48] Predictors of Poor Outcome of Infliximab Therapy in Ulcerative Colitis
    Ebrahim, Vivian
    Wu, Xianrui
    Shen, Bo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S485 - S485
  • [49] Infliximab Versus Combination Infliximab and Immunosuppressant Therapy for Patients With Active Ulcerative Colitis: A Meta-Analysis
    Christophorou, Dimitri
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Daures, Jean-Pierre
    Blanc, Pierre
    GASTROENTEROLOGY, 2014, 146 (05) : S249 - S249
  • [50] Infliximab versus combination infliximab and immunosuppressant therapy for patients with active ulcerative colitis: a meta-analysis
    Christophorou, D.
    Funakoshi, N.
    Duny, Y.
    Valats, J-C
    Bismuth, M.
    Daures, J-P
    Blanc, P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S250 - S250
12345